CoalaLife signs an agreement with an US clinic to monitor an initial 400 patients under RPM and PCM

Regulatory

CoalaLife has signed an agreement with a prominent cardiology practice for RPM, PCM and billing services. The program was started upon signing and is expected to expand to over 2.000 patients during the first half of 2024. The practice will also utilize the Coala Heart Monitor as an unique addition to their standard diagnostic technologies.
 
“Our comprehensive offering, proprietary framework and our Coala Heart Monitor has positioned the Company as a leader within the RPM/PCM market. With our robust customer pipeline we are looking forward to an exciting 2024” says CEO Dan Pitulia.

About us

Coala-Life Group AB (“Coala Life” or the “Company”) founded in 2015, is a Cloud Based Software as a Service provider, and medical device developer and reseller, listed on Nasdaq First North Growth Market. The Company focuses on B2B solutions for managed Remote Patient Monitoring (“RPM”), offering medical care providers, primarily in the US, with a highly scalable, cost-efficient platform to remotely and virtually manage large volumes of patients suffering from chronic diseases. The company offers care providers a comprehensive solution and lifts the administrative work from the care providers regarding, amongst other things, follow-up, 24/7 monitoring, as well as the reimbursement process from state and private health insurance companies. Patients are monitored long-term in everyday life and typically have diabetes, obesity, and/or cardiovascular disease. 
For more information see www.coalalife.com

For more information, please contact:

Dan Pitulia, CEO Coala Life AB
+44 7849 257 532, dan.pitulia@coalalife.com
Robin Danielsson Källmark, Interim CFO Coala Life AB
+46 72 188 84 09, robin.danielsson.kallmark@coalalife.com

Certified Adviser
The Company’s Certified Adviser is Carnegie Investment Bank AB (publ).

This information is information that Coala Life is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2024-01-10 08:50 CET.

Attachments

CoalaLife signs an agreement with an US clinic to monitor an initial 400 patients under RPM and PCM

Documents